Article
Next-generation sequencing in familial breast cancer patients from Lebanon.
BMC medical genomics - 15 Feb 2017
Jalkh Nadine, Chouery Eliane, Haidar Zahraa, Khater Christina, Atallah David, Ali Hamad, Marafie Makia J, Al-Mulla Mohamed R, Al-Mulla Fahd, Megarbane Andre
Abstract excerpt
BACKGROUND: Familial breast cancer (BC) represents 5 to 10% of all BC cases. Mutations in two high susceptibility BRCA1 and BRCA2 genes explain 16-40% of familial BC, while other high, moderate and low susceptibility genes explain up to 20% more of BC families. The Lebanese reported prevalence of BRCA1 and BRCA2 deleterious mutations (5.6% and 12.5%) were lower than those reported in the literature. METHODS: In...
Topics
Join the communities discussing this publication.
